Skip to content

Clinical efficacy of percutaneous auricular vagus nerve stimulation to relieve post-operative pain after sleeve gastrectomy through autonomic modulation

Clinical efficacy of percutaneous auricular vagus nerve stimulation to relieve post-operative pain after sleeve gastrectomy through autonomic modulation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087715
Enrollment
Unknown
Registered
2024-08-02
Start date
2024-08-11
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after sleeve gastrectomy

Interventions

stimulus group:The stimulation group received active electrical stimulation of the left eustachian tube with a stimulation frequency of 25Hz, pulse width of 200µs, 30s on/30s off for 3 days (the first
Pseudostimulus group:The sham stimulation group then received the same cycle of treatment, with the sham stimulation being placed via electrodes on the left side of the ear nail boat, and the same met

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old (inclusive). 2. Body mass index (BMI) > 35 kg/m2 and elective laparoscopic sleeve gastrectomy under general anesthesia. 3. American Society of Anesthesiologists classification (ASA) 1-3. 4. Be able to understand the study process and the use of various assessment scales, and be able to communicate effectively with the researchers. 5. Voluntarily participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of previous abdominal surgery, including esophageal, gastric, hepatic and pancreatic resections. 2. Patients with severe underlying cardiovascular disease (e.g., congestive heart failure, conduction disorders, and ischemic heart disease). 3. Patients with neuromuscular diseases and left auricular dermatitis. 4. Patients with chronic pain and long-term opioid use. 5. Patients who are unable to cooperate with the evaluation. 6. Patients who have had seizures or recurrent syncope within the last 5 years. 7. Previous transient ischemic attack or cerebrovascular accident. 8. Patients who have received vagus nerve stimulation or acupuncture within 1 month prior to the study. 9. Vulnerable groups, including mentally ill, cognitively impaired, critically ill, pregnant women, illiterate, etc.

Design outcomes

Primary

MeasureTime frame
Postoperative pain score;

Secondary

MeasureTime frame
Basic information, such as height, weight, BMI, gender, age, hypertension history, diabetes history and preoperative pulmonary function;Surgical conditions, such as surgical duration, crystalloid infusion volume, blood transfusion volume, urine output, postoperative extubation time, and PACU retention time;vital signs;Postoperative opioid consumption and pain scores;Quality of postoperative recovery;adverse event;

Countries

China

Contacts

Public ContactGang Chen

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

chengang120@zju.edu.cn+86 137 5711 8681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026